AMPK beta 1 (PRKAB1) Human shRNA Plasmid Kit (Locus ID 5564)
CAT#: TG315591
PRKAB1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
PRKAB1 mouse monoclonal antibody,clone OTI8D5
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | AMPK beta 1 (PRKAB1) Human shRNA Plasmid Kit (Locus ID 5564) |
Locus ID | 5564 |
UniProt ID | Q9Y478 |
Synonyms | AMPK; HAMPKb |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | PRKAB1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5564). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_006253, NM_006253.1, NM_006253.3, NM_006253.4, BC017671, BC017671.1, BC001007, BC001056, BC001823, BC018818, NM_006253.5 |
Summary | The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit may be a positive regulator of AMPK activity. The myristoylation and phosphorylation of this subunit have been shown to affect the enzyme activity and cellular localization of AMPK. This subunit may also serve as an adaptor molecule mediating the association of the AMPK complex. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Reduced expression of AMPK-ß1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer
,Li, C;Liu, VW;Chiu, PM;Yao, KM;Ngan, HY;Chan, DW;,
Mol. Cancer
,PubMed ID 24602453
[PRKAB1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...